Stephen Canfield, DO
Hospitalist · Fort Myers, FLNPI 1326542135
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 15 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Johnson & Johnson at 28.7% of the total. Reporting peaked in 2022 at $100 and has fallen 85.9% since, to $14 in 2023.
Across 15 payments — averaging $16.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$69
- Novartis$52
- Dexcom, Inc.$44
- Novo Nordisk$37
- Amgen$13
- Eisai Inc.$13
- plus $12 from 1 others
What the payments were for
- Food & beverage$241100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 4 | $69 |
| Novartis | 3 | $52 |
| Dexcom, Inc. | 3 | $44 |
| Novo Nordisk | 2 | $37 |
| Amgen | 1 | $13 |
| Eisai Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
How this compares
$241 in reported general payments places this provider in the 55th percentile of 1,570 hospitalist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefdinir | 35 | $377 |
| Metoprolol Succinate | 13 | $92 |
| Pantoprazole Sodium | 16 | $81 |
| Metronidazole | 17 | $81 |
| Ciprofloxacin Hcl | 15 | $79 |
| Doxycycline Hyclate | 15 | $63 |
| Metoprolol Tartrate | 12 | $58 |
| Oxycodone Hcl | 18 | $48 |
| Prednisone | 19 | $46 |
| Furosemide | 13 | $30 |
| Amlodipine Besylate | 13 | $23 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Fort Myers
- Oliver AbelaFort Myers$77K
- Iahn GonsenhauserFort Myers$8K
- Vinod KumarFort Myers$4K
- Tanzeen AhmedFort Myers$3K
- Katharine van FossenFort Myers$3K
- Murray EpsteinMiami$370K
- Joshua LenchusFort Lauderdale$73K
- Tuncay TaskesenThe Villages$22K
- Diego MunozApopka$17K
- Francisco Perez LoretoMiami$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.